|

Dalpiciclib 100mg Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • West China Hospital2

Indications

  • Cancer2
  • Esophageal Squamous Cell Carcinoma1
  • Head and Neck Squamous Cell Carcinoma1

Other2 trials

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
Phase 1
Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.